Drug intelligence / Profile preview

TUMS Chewy Bites with Gas Relief

Development stage: Unknown
Lead developer: GSK
Modality: Small Molecules
Administration: Oral

Overview

TUMS Chewy Bites with Gas Relief is an over-the-counter (OTC) combination medication designed to treat symptoms of acid reflux and intestinal gas. It contains two active ingredients: calcium carbonate, a small molecule antacid that neutralizes gastric acid to relieve heartburn and indigestion, and simethicone, an anti-foaming agent that reduces the surface tension of gas bubbles in the digestive tract to alleviate bloating and pressure. Manufactured by Haleon (formerly part of GSK), the product is formulated as chewable tablets with a crunchy outer shell and a soft center. It is indicated for the relief of heartburn, acid indigestion, sour stomach, and associated gas or bloating.

Brand names: TUMS Chewy Bites with Gas Relief

Beyond the preview

Go deeper on TUMS Chewy Bites with Gas Relief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TUMS Chewy Bites with Gas Relief.

Explore the full profile